ImpactOS
See an example

European Confederation of Pharmaceutical Entrepreneurs

Trade and business associations · Belgium

In these lists: Medicines

Declared lobbying cost
€800,000 – €899,999 Financial year 01/2025-12/2025
Commission meetings
12
Full-time staff on EU lobbying
4.45
European Parliament access passes
10
Registered since
15 Apr 2009
Public records onlyWhat this means

Every profile, record and figure comes from documents published by EU institutions, national authorities, courts, ethics bodies, the EU Transparency Register or established news outlets. We use no leaks, private data or anonymous tips. AI helps us gather and cross-check sources but never decides anyone's guilt: each record keeps its exact legal status and links to its source, so you can check it yourself

Registering is a legal transparency duty, not a sign of wrongdoing. Budgets and meetings show access, not influence on any particular decision. Register figures as declared on 30 Jun 2026

Fields of interest

Business and industry, Competition, Consumers, Digital economy and society, Economy, finance and the euro, Food safety, Institutional affairs, Public health, Research and innovation, Single market, Trade

Medicines and food topics they name

EU medicines law, Critical medicines, Orphan and paediatric medicine incentives, Health technology assessment

EU laws and policies they declare following15
  • Any legislative proposal or policy related to or affecting healthcare/public health/life sciences, in particular the general legal framework for medicinal products and medical devices as well as orph…
  • Industrial Strategy.
  • Trade.
  • The main EU legislative proposals, policies or files EUCOPE is engaged with are the below (this is not an exhaustive list):
  • A Pharmaceutical Strategy for Europe
  • Orphan Medicinal Products Regulation
  • Paediatrics Regulation
  • Directive 2001/83/EC on the Community code relating to medicinal products for human use
  • Regulation No 726/2004 laying down Union procedures for the authorisation and supervision of medicinal products for human use and establishing a European Medicines Agency
  • Substances of Human Origins Regulation
  • ATMPs Regulation
  • Clinical Trials Regulation
  • EU Regulation on health technology assessment
  • European Health Data Space
  • HERA Regulation

Meetings with the Commission

Meetings with Commissioners or their Cabinets since 1 December 2024, as the Commission publishes them

  1. With the Commissioner

    Olivér Várhelyi

    Health industry roundtable

    Published record
  2. With the Cabinet

    Olivér Várhelyi

    Health industry roundtable

    Published record
  3. With the Commissioner

    Olivér Várhelyi

    Health industry roundtable

    Published record
  4. With the Cabinet

    Olivér Várhelyi

    Health industry roundtable

    Published record
  5. With the Commissioner

    Olivér Várhelyi

    Situation of medium sized innovative pharma sector

    Published record
  6. With the Cabinet

    Olivér Várhelyi

    Situation of medium sized innovative pharma sector

    Published record
  7. With the Commissioner

    Olivér Várhelyi

    All pressing portfolio topics

    Published record
  8. With the Cabinet

    Olivér Várhelyi

    All pressing portfolio topics

    Published record
  9. With the Cabinet

    Ekaterina Zaharieva

    Life sciences

    Published record
  10. With the Commissioner

    Olivér Várhelyi

    EU biotech policy

    Published record

See all 12 meetings

Official entries

Checked against sources on 11 Nov 2026